Treatment of Huntington disease with gamma-acetylenic GABA an irreversible inhibitor of GABA-transaminase: increased CSF GABA and homocarnosine without clinical amelioration.

G Tell; P Böhlen; P J Schechter; J Koch-Weser; Y Agid; A M Bonnet; G Coquillat; G Chazot; C Fischer

doi:10.1212/wnl.31.2.207

Treatment of Huntington disease with gamma-acetylenic GABA an irreversible inhibitor of GABA-transaminase: increased CSF GABA and homocarnosine without clinical amelioration.

Identifier:nobleid.org/w1/20260515/C1DF4CD4

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C1DF4CD4.svg?ark=w1%2F20260515%2FC1DF4CD4)](https://nobleid.org/work/w1/20260515/C1DF4CD4)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Treatment of Huntington disease with gamma-acetylenic GABA an irreversible inhibitor of GABA-transaminase: increased CSF GABA and homocarnosine without clinical amelioration.

Identifier:nobleid.org/w1/20260515/C1DF4CD4

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C1DF4CD4.svg?ark=w1%2F20260515%2FC1DF4CD4)](https://nobleid.org/work/w1/20260515/C1DF4CD4)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work